Laurus Labs Limited has announced a further investment of ₹34.99 crore (Indian Rupees Thirty Four Crores Ninety Nine Lakhs Eighty Seven Thousand Nine Hundred and Nineteen and Paise Seventy Four Only) in its subsidiary, Laurus Bio Private Limited. This investment was made through the acquisition of 13,487 Series A 3 Compulsorily Convertible Preference Shares at a face value of ₹100 and a premium of ₹25,850.02 each. Following this additional investment, Laurus Labs' shareholding in Laurus Bio has increased to 75.61% on a fully diluted basis. This announcement is made in continuation of the company's earlier intimation dated December 06, 2024, and in accordance with Regulation 30(7) of SEBI (LODR) Regulations, 2015.